Result Summaries: GSK323527
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| 101222 | Phase 3 | Study to demonstrate the non-inferiority of GSK Bios’ DTPw-HBV/Hib Kft. vaccine compared to GSK Bios’ Tritanrix™-HepB/Hiberix™ vaccine and to separate administration of DTPw-HBV Kft. and Hiberix™ vaccines with respect to the immunogenicity of all antigens, when administered to healthy infants. (2 citation(s)) |  |